– NYSE:BCSF
stock price today
$15.17
-2.52
-14.29%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
stock price monthly change
+6.63%
month
stock price quarterly change
+6.63%
quarter
stock price yearly change
+13.53%
year
key metrics
Market Cap | 1.10B |
Enterprise value | 2.41B |
P/E | 8.90 |
EV/Sales | 8.11 |
EV/EBITDA | 46.66 |
Price/Sales | 3.84 |
Price/Book | 0.99 |
PEG ratio | 0.08 |
EPS | 1.99 |
Revenue | 243.47M |
EBITDA | 181.46M |
Income | 129.18M |
Revenue Q/Q | 142.79% |
Revenue Y/Y | 115.20% |
Profit margin | 43.15% |
Oper. margin | 68.75% |
Gross margin | 77.5% |
EBIT margin | 68.75% |
EBITDA margin | 74.53% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freestock price history
stock forecast
financial statements
| Jun 2023 | 32.39M | 29.17M | 90.06% |
|---|---|---|---|
| Sep 2023 | 37.67M | 33.85M | 89.87% |
| Dec 2023 | 95.00M | 31.06M | 32.7% |
| Mar 2024 | 78.40M | 35.09M | 44.76% |
| Mar 2024 | 78.40M | 35.09M | 44.76% |
|---|---|---|---|
| Sep 2025 | 62.7M | 30.34M | 48.4% |
| Oct 2025 | 68.9M | 30.34M | 44.04% |
| Dec 2025 | 67.6M | 32.28M | 47.75% |
Analysts Price target
Financials & Ratios estimates
7.62%
Yield TTM
| Payout ratio | 87.53% |
|---|
| 2019 | 7.86% |
|---|---|
| 2020 | 12.12% |
| 2021 | 8.94% |
| 2022 | 11.43% |
| 2023 | 10.22% |
| Jun 2023 | 2675388000 | 1.54B | 57.92% |
|---|---|---|---|
| Sep 2023 | 2566475000 | 1.43B | 55.87% |
| Dec 2023 | 2472348000 | 1.33B | 54.03% |
| Mar 2024 | 2580113000 | 1.43B | 55.72% |
| Jun 2023 | -8.77M | -47.33M | 56.46M |
|---|---|---|---|
| Sep 2023 | 122.31M | 23.33M | -144.53M |
| Dec 2023 | 24.71M | 123.97M | -142.11M |
| Mar 2024 | 44.78M | -108.47M | 73.88M |
other data
47.36%
-5.01%
of BCSF is owned by hedge funds
80
-38
30.57M
-3.23M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2022 | 1300 | 0 |
| Mar 2022 | 9361 | 0 |
| Aug 2022 | 3400 | 0 |
| Quarter | Transcript |
|---|---|
| Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 28 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 9 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of stock today?
One share of stock can currently be purchased for approximately $15.17.
-
When is 's next earnings date?
Unfortunately, 's (BCSF) next earnings date is currently unknown.
-
Does pay dividends?
Yes, pays dividends and its trailing 12-month yield is 7.63% with 88% payout ratio. The last stock dividend of $0.34 was paid on 28 Jan 2022.
-
How much money does make?
has a market capitalization of 1.10B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 155.6% to 297.79M US dollars.
-
What is 's stock symbol?
null is traded on the NYSE under the ticker symbol "BCSF".
-
What is 's primary industry?
Company operates in the Financial Services sector and Asset Management industry.
-
How do i buy shares of ?
Shares of can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When went public?
null is publicly traded company for more then 6 years since IPO on 15 Nov 2018.
-
What is 's official website?
The official website for is baincapitalbdc.com.
-
Where are 's headquarters?
is headquartered at 200 Clarendon Street, Boston, MA.
-
How can i contact ?
's mailing address is 200 Clarendon Street, Boston, MA and company can be reached via phone at +61 75162318.
company profile:
Exchange:
NYSE
Full time employees:
0
Industry:
Asset Management
Sector:
Financial Services
Bain Capital Specialty Finance, Inc. is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.
200 Clarendon Street
Boston, MA 02116
Boston, MA 02116
CIK: 0001655050
ISIN: US05684B1070
CUSIP: 05684B107
